Abstract
We have previously shown that Candida albicans mannan extract encapsulated in liposomes [Lipo-mann] or conjugated to a protein (bovine serum albumin) [Conju-mann] induces the production of antibody in BALB/c mice with normal complement system that protect against disseminated candidiasis. In this present study, we determined the protective abilities of two formulae in a C5-deficient mouse model of disseminated candidiasis. It is known that the lack of C5 is known to aggravate candidal infection. In experiments, BALB/c or C5-deficient mice-DBA/2J and AKR mice, were immunized with one of the formulae before intravenous challenge with live C. albicans yeast cells and their degrees of survivability were measured. Results showed that Conju-mann was 100% protective in BALB/c mice against disseminated candidiasis, whereas only 60% of Lipo-mann immunized mice survived the entire 50 day observation period (p < 0.05). With the DBA/2J strain, Conju-mann resulted in a partial protection, but Lipo-mann had no protection. The conjugate vaccine enhanced the resistance of AKR mice, which resulted in three survivors of the five Conju-immunized AKR mice until the end of 50 day observation period (p < 0.05). Lipo-mann showed little protection in AKR mice. By agglutination analyses, it was determined that there was the same level of production of polyclonal antisera specific to the mannan regardless of the mouse strains. All data indicate that both formulations require complement in the protection. However, Conju-mann appears to be superior to Lipo-mann because the conjugate vaccine is protective even in the absence of C5. These observations suggest that the conjugate vaccine can be an excellent vaccine formulation against C. alibicans infections.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Ashman, R. B., Fulurija, A., and Papadimitriou, J. M., Strain-dependent differences in host response to Candida albicans infection in mice are related to organ susceptibility and infectious load. Infect. Immun., 64, 1866–1869 (1996).
Ashman, R. B., Papadimitriou, J. M., Fulurija, A., Drysdale, K. E., Farah, C. S., Naidoo, O., and Gotjamanos, T., Role of complement C5 and T lymphocytes in pathogenesis of disseminated and mucosal candidiasis in susceptible DBA/2 mice. Microb. Pathog., 34, 103–113 (2003).
Caesar-TonThat, T. C. and Cutler, J. E., A monoclonal antibody to Candida albicans enhances mouse neutrophil candidacidal activity. Infect. Immun., 65, 5354–5357 (1997).
Cheng, S. C., Sprong, T., Joosten, L. A., van der Meer, J. W., Kullberg, B. J., Hube, B., Schejbel, L., Garred, P., van Deuren, M., and Netea, M. G., Complement plays acentral role in Candida albicans-induced cytokine production by human PBMCs. Eur. J. Immunol., 42, 993–1004 (2012).
Costantino, P. J., Gare, N. F., and Warmington, J. R., Humoral immune responses to systemic Candida albicans infection in inbred mouse strains. Immunol. Cell Biol., 73, 125–133 (1995).
Han, Y., van Rooijen, N., and Cutler, J. E., Binding of Candida albicans yeast cells to mouse popliteal lymph node tissue is mediated by macrophages. Infect. Immun., 61, 3244–3249 (1993).
Han, Y. and Cutler, J. E., Antibody response that protects against disseminated candidiasis. Infect. Immun., 63, 2714–2719 (1995).
Han, Y., Kanbe, T., Cherniak, R., and Cutler, J. E., Biochemical characterization of Candida albicans epitopes that can elicit protective and nonprotective antibodies. Infect. Immun., 65, 4100–4107 (1997).
Han, Y., Morrison, R. P., and Cutler, J. E., A vaccine and monoclonal antibodies that Enhance mouse resistance to Candida albicans vaginal infection. Infect. Immun., 66, 5771–5776 (1998).
Han, Y., Ulrich, M. A., and Cutler, J. E., Candida albicans mannan extract-protein conjugates induce a protective immune response against experimental candidiasis. J. Infect. Dis., 179, 1477–1484 (1999).
Han, Y., Riesselman, M. H., and Cutler, J. E., Protection against candidiasis by an immunoglobulin G3 (IgG3) monoclonal antibody specific for the same mannotriose as an IgM protective antibody. Infect. Immun., 68, 1649–1654 (2000).
Han, Y., Kozel, T. R., Zhang, M. X., MacGill, R. S., Carroll, M. C., and Cutler, J. E., Complement is essential for protection by an IgM and an IgG3 monoclonal antibody against experimental, hematogenously disseminated candidiasis. J. Immun., 67, 1550–1557 (2001).
Han, Y., Ginkgo terpene component has an anti-inflammatory effect on Candida albicans-caused arthritis. Int. Immunopharmacol., 5, 1049–1056 (2005).
Han, Y. and Lee, J. H., Berberine synergy with amphotericin B against disseminated candidiasis in mice. Biol. Pharm. Bull., 28, 541–544 (2005).
Han, Y., Synergic anticandidal effect of epigallocatechin-Ogallate combined with amphotericin B in a murine model of disseminated candidiasis and its anticandidal mechanism. Biol. Pharm. Bull., 30, 1693–1696 (2007).
Han, Y., Efficacy of combination immunotherapy of IgM MAb B6.1 and amphotericin B against disseminated candidiasis. Int. Immunopharmacol., 10, 1526–1531 (2010).
Hazen, K. C., Brawner, D. L., Riesselman, M. H., Jutila, M. A., and Cutler, J. E., Differential adherence of hydrophobic and hydrophilic Candida albicans yeast cells to mouse tissues. Infect. Immun., 59, 907–912 (1991).
Kanbe, T., Han, Y., Redgrave, B., Riesselman, M. H., and Cutler, J. E., Evidence that mannans of Candida albicans are responsible for adherence of yeast forms to spleen and lymph node tissue. Infect. Immun., 61, 2578–2584 (1993).
Kanbe, T. and Cutler, J. E., Evidence for adhesin activity in the acid-stable moiety of the phosphomannoprotein cell wall complex of Candida albicans. Infect. Immun., 62, 1662–1668 (1994).
Kim, J., Han, B. J., Kim, H., Lee, J. Y., Joo, I., Omer, S., Kim, Y. S., and Han, Y., Th1 immunity induction by ginsenoside Re involves in protection of mice against disseminated candidiasis due to Candida albicans. Int. Immunopharmacol., 14, 481–486 (2012).
Lee, J. H. and Han, Y., Ginsenoside Rg1 helps mice resist to disseminated candidiasis by Th1 type differentiation of CD4+ T cell. Int. Immunopharmacol., 6, 1424–1430 (2006).
Lee, J. H., Park, J. H., Kim, Y. S., and Han, Y., Chlorogenic acid, a polyphenolic compound, treat mice with septic arthritis caused by Candida albicans. Int. Immunopharmacol., 8, 681–685 (2008).
Mullick, A., Leon, Z., Min-Oo, G., Berghout, J., Lo, R., Daniels, E., and Gros, P., Cardiac failure in C5-deficient A/J mice after Candida albicans infection. Infect. Immun., 74, 4439–4451 (2006).
Radovanovic, I., Mullick, A., and Gros, P., Genetic control of susceptibility to infection with Candida albicans in mice. PLoS One, 6, e18957 (2011).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Han, Y., Rhew, K.Y. Comparison of two Candida mannan vaccines: The role of complement in protection against disseminated candidiasis. Arch. Pharm. Res. 35, 2021–2027 (2012). https://doi.org/10.1007/s12272-012-1120-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12272-012-1120-9